OTLK

Outlook Therapeutics Inc
1.12
-0.04 (-3.45%)
1.12
Volume 482,765
Bid Price 1.12
Ask Price 1.19
News -
Day High 1.18

Low
0.6839

52 Week Range

High
2.12

Day Low 1.11
Company Name Stock Ticker Symbol Market Type
Outlook Therapeutics Inc OTLK NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.04 -3.45% 1.12 17:20:49
Open Price Low Price High Price Close Price Prev Close
1.16 1.11 1.18 1.17 1.16
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,108 482,765 $ 1.15 $ 553,999 - 0.6839 - 2.12
Last Trade Time Type Quantity Stock Price Currency
18:44:34 10 $ 1.19 USD

Period:

Draw Mode:

Outlook Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 287.47M 256.67M 180.71M $ - $ - -0.31 -3.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 14.90M 4.30%

more financials information »

Outlook Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical OTLK Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.091.201.081.15335,4000.032.75%
1 Month1.041.371.011.18577,2600.087.69%
3 Months1.071.370.801.08482,5700.054.67%
6 Months1.121.370.801.14481,3630.000.0%
1 Year1.402.120.68391.41801,636-0.28-20.0%
3 Years0.964.260.4991.721,641,3870.1616.67%
5 Years5.6020.000.40111.881,608,814-4.48-80.0%

Outlook Therapeutics Description

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.